Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leuschner

Showing results (71-80 of 1,492) with videos related to

Pageof 150
Sort By:
Circulation Research|March 5, 2011
Molecular imaging of coronary atherosclerosis and myocardial infarction: considerations for the bench and perspectives for the clinicFlorian Leuschner, Matthias Nahrendorf
Biomedizinische Technik. Biomedical Engineering|March 1, 1990
Preclinical safety testing of plastic products intended for use in manJ Leuschner, M Rimpler
Current Pharmaceutical Design|July 29, 2004
Membrane disrupting lytic peptides for cancer treatmentsCarola Leuschner, William Hansel
Arzneimittel-Forschung|December 1, 1994
Twenty-six-week oral toxicity study of benzalazine in dogsR Herzog, J Leuschner
Arzneimittel-Forschung|December 1, 1994
Reproductive toxicity studies of benzalazine in rats and rabbitsR Herzog, J Leuschner
Arzneimittel-Forschung|March 1, 1995
Evaluation of the mutagenicity of medroxyprogesterone acetate in vitro and in vivoR Herzog, J Leuschner
Progress in Clinical and Biological Research|January 1, 1984
Chemical dissolution of common bile duct stonesU Leuschner, H Baumgärtel
Photochemistry and Photobiology|February 27, 2013
Characterizing ultraviolet germicidal irradiance luminairesWilhelm Leuschner, Faatiema Salie
Psychiatrie, Neurologie, Und Medizinische Psychologie|August 1, 1980
[Clinical and neurophysiological findings in serum controlled diphenylhydantoin application - considerations on myotonic dystrophy therapy]D Müller, U Leuschner
Journal of Hepatology|October 1, 1994
Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosisU Leuschner, S Güldütuna, M Imhof, et al.
Pageof 150

Showing results (71-80 of 1,492) with videos related to

Sort By:
Pageof 150
Circulation Research|March 5, 2011
Molecular imaging of coronary atherosclerosis and myocardial infarction: considerations for the bench and perspectives for the clinicFlorian Leuschner, Matthias Nahrendorf
Biomedizinische Technik. Biomedical Engineering|March 1, 1990
Preclinical safety testing of plastic products intended for use in manJ Leuschner, M Rimpler
Current Pharmaceutical Design|July 29, 2004
Membrane disrupting lytic peptides for cancer treatmentsCarola Leuschner, William Hansel
Arzneimittel-Forschung|December 1, 1994
Twenty-six-week oral toxicity study of benzalazine in dogsR Herzog, J Leuschner
Arzneimittel-Forschung|December 1, 1994
Reproductive toxicity studies of benzalazine in rats and rabbitsR Herzog, J Leuschner
Arzneimittel-Forschung|March 1, 1995
Evaluation of the mutagenicity of medroxyprogesterone acetate in vitro and in vivoR Herzog, J Leuschner
Progress in Clinical and Biological Research|January 1, 1984
Chemical dissolution of common bile duct stonesU Leuschner, H Baumgärtel
Photochemistry and Photobiology|February 27, 2013
Characterizing ultraviolet germicidal irradiance luminairesWilhelm Leuschner, Faatiema Salie
Psychiatrie, Neurologie, Und Medizinische Psychologie|August 1, 1980
[Clinical and neurophysiological findings in serum controlled diphenylhydantoin application - considerations on myotonic dystrophy therapy]D Müller, U Leuschner
Journal of Hepatology|October 1, 1994
Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosisU Leuschner, S Güldütuna, M Imhof, et al.
Pageof 150